narsoplimab-wuug

narsoplimab-wuug (YARTEMLEA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

YARTEMLEA is a marketed brand name for narsoplimab-wuug. Check FDA Drugs@FDA for the current US label holder and prescribing information.

narsoplimab-wuug has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.